3 lotion companies fail to prove ‘skin whitening’ claims, fined

NEW DELHI:  Advertisements on e-commerce platforms that claim certain body lotion can whiten your skin in just minutes always sounded fictitious. What you doubted has turned out to be true. In three recent cases, companies have admitted to the Central Consumer Protection Authority (CCPA) that these were exaggerations and they resorted to such claims of “unique selling point (USP)” to just come up on e-commerce platforms.

In orders passed by the CCPA in Feb against four companies selling whitening creams and body lotion, including the three which cited USP, the consumer watchdog has recorded how the companies failed to substantiate their claims. They withdrew their advertisements from e-commerce platforms after the authority issued notices to them.

In all these cases, investigations by the Bureau of Indian Standards confirmed that the companies failed to provide any scientific validation to their claims or any proof to support their claims. It has imposed fines on these entities and instructed them not to make such unverified and unsubstantiated claims. It cautioned them of a Rs 50 lakh fine for repeat of offence.

Interestingly, in all the four cases, the companies claimed they were unaware of the law against misleading advertisements of the CCPA.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices